@article{CJCR1439,
author = {Paul E. Van Schil},
title = {Treatment of mesothelioma: still a long way to go!},
journal = {Chinese Journal of Cancer Research},
volume = {25},
number = {2},
year = {2013},
keywords = {},
abstract = {Prognosis of patients with malignant pleural mesothelioma remains very poor. Single treatment modality is clearly not effective in improving disease-free and overall survival. For this reason combined modality therapy is intensively investigated. In the well-performed and timely systematic review by Cao and colleagues, results of trimodality therapy for mesothelioma consisting of neoadjuvant or adjuvant chemotherapy, extrapleural pneumonectomy and adjuvant radiotherapy, were evaluated (1).},
issn = {1993-0631}, url = {https://cjcr.amegroups.org/article/view/1439}
}